New Technique to Control Killer Disease Offered Multi Million Dollar Funding

Wednesday, June 29th 2005

29 June, 2005New Technique to Control Killer Disease Offered Multi Million Dollar FundingOxitec Limited is pleased to announce that it is a member of a consortium that has been offered funding to develop new genetic strategies for control of dengue virus. On Tuesday 28th June 2005 the Foundation for the National Institutes of Health (NIH) more »

Oxford Capital Partners leads second round investment in Oxitec

Wednesday, June 8th 2005

Oxitec Limited announces the completion of its second funding round of 1.3m pounds, led by Oxford Capital Partners. The existing investors, East Hill Advisors, LLC from Boston and the University of Oxford (through the Isis College Fund), have made further investments in the company as part of this round. Oxford Capital Partners invested 550,000 pounds. more »